Milestone Pharmaceuticals announces FDA acceptance of response to Cardamyst nasal spray CRL
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Azelis will strengthen its presence in the domestic market by leveraging portfolio synergies, actively consolidating the business, and creating value for all stakeholders
It is intended for contrast enhancement in MRI scans
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
Subscribe To Our Newsletter & Stay Updated